Position in SPTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$132,526,361
New position
Shares Held
6,101,582
first reported quarter
Ownership
11.4%
of shares outstanding
% of Portfolio
4.56%
of 13F equity value
Holder Rank
#2
of 54 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026GENERAL ATLANTIC, L.P. holds $541,727,121 across 5 Biotechnology names. SPTX ranks #2 (24.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PHVS |
Pharvaris N.V.
|
6,550,757 | $226,525,177 | |
| 2 | SPTX |
Seaport Therapeutics, Inc.
This page
|
6,101,582 | $132,526,361 | |
| 3 | NRIX |
Nurix Therapeutics, Inc.
|
3,032,185 | $73,560,808 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
357,791 | $67,007,098 | |
| 5 | PBLS |
Parabilis Medicines, Inc.
|
1,538,461 | $42,107,677 |
All Filings in SPTX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $132,526,361 | 6,101,582 | Shares | Sole | 2026-08-14 | |
| 2026-05-04 | $103,726,894 | 6,101,582 | Shares | Sole | 2026-05-11 | |
| No filing history on record for this holder in this stock. | ||||||